Mark J Gemkow

Summary

Affiliation: Evotec AG
Country: Germany

Publications

  1. ncbi The histamine H3 receptor as a therapeutic drug target for CNS disorders
    Mark J Gemkow
    Evotec AG, Schnackenburgallee 114, 22525 Hamburg, Germany
    Drug Discov Today 14:509-15. 2009

Detail Information

Publications1

  1. ncbi The histamine H3 receptor as a therapeutic drug target for CNS disorders
    Mark J Gemkow
    Evotec AG, Schnackenburgallee 114, 22525 Hamburg, Germany
    Drug Discov Today 14:509-15. 2009
    ..Whether a single compound profile for the treatment of different disorders can be defined remains to be seen...